<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The case of a woman with congenital antithrombin III (AT III) deficiency undergoing elective hysterectomy is reported </plain></SENT>
<SENT sid="1" pm="."><plain>AT III deficient patients have high risks of <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo>, especially developing during and after surgery </plain></SENT>
<SENT sid="2" pm="."><plain>It is usual practice to discontinue oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> with antivitamin K activity and to obtain effective AT III activity by the transfusion of freeze-dried concentrates of AT III and/or fresh frozen plasma (FFP) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> is prescribed as soon as AT III activity reaches 70% </plain></SENT>
<SENT sid="4" pm="."><plain>The oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> regimen is reinstituted in the late postoperative period </plain></SENT>
<SENT sid="5" pm="."><plain>In our case, transfusion of FFP, in the pre- and postoperative periods, results in an AT III activity of 63% </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> was not used because oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> were readministered early, 12 h after operation </plain></SENT>
<SENT sid="7" pm="."><plain>No clinical thrombo-embolic complication was observed </plain></SENT>
</text></document>